Clinical Research Directory

Inclusion Criteria: The main inclusion criteria include but are not limited to the following: * Has a diagnosis of sarcoidosis of ≥6 months before Screening confirmed by tissue biopsy * Has lung parenchymal involvement consistent with pulmonary sarcoidosis (PS) by chest X-ray or chest high-resolution computed tomography (HRCT) either via historical evidence or at Screening * Has active PS within 3 months before Screening Exclusion Criteria: The main exclusion criteria include but are not limited to the following: * Has a history of cancer and is disease free for \<5 years * Has cardiac, ocular, neurosarcoidosis, or other manifestations of sarcoidosis that requires systemic treatment that may interfere with protocol specifications, or has a clinically significant electrocardiogram abnormality that requires evaluation or intervention * Is receiving treatment for pulmonary hypertension * Has a history of fungal respiratory infection within 12 months before screening without documentation of completed treatment * Has a diagnosis of or currently has a clinical presentation consistent with Löfgren syndrome * Has active tuberculosis (TB) or history of active TB * Has any condition that may interfere with the ability to adhere to oral corticosteroid therapy or taper * Is a current smoker defined as smoking or vaping of inhaled preparations of nicotine, tobacco, or cannabis preparations within 6 months before Screening